Notify me when DAWEI LUO files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VVOS | Vivos Therapeutics Inc. | Common stock, par value $0.0001 per share | 8.5% | $1,784,690 | 572,016 | Dawei Luo | 08 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|